<div id="readability-page-1"><p>OneMedNet Corporation (NASDAQ:ONMD - Get Free Report) Director Thomas Kosasa bought 595,238 shares of OneMedNet stock in a transaction that occurred on Friday, February 6th. The shares were bought at an average cost of $0.84 per share, with a total value of $499,999.92. Following the acquisition, the director directly owned 16,380,429 shares in the company, valued at $13,759,560.36. This trade represents a 3.77% increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website.</p><ul><li>Palantir’s New Healthcare Deal Boosts AI and Data Reach </li></ul><p>Thomas Kosasa also recently made the following trade(s): </p><ul><li>On Thursday, April 23rd, Thomas Kosasa purchased 280,898 shares of OneMedNet stock. The stock was bought at an average cost of $0.89 per share, for a total transaction of $249,999.22. </li></ul><h2>OneMedNet Trading Up 24.1%</h2><p>ONMD stock traded up $0.21 during mid-day trading on Friday, hitting $1.10. 821,198 shares of the company were exchanged, compared to its average volume of 3,251,295. The business has a 50 day simple moving average of $0.79 and a 200-day simple moving average of $1.26. The stock has a market capitalization of $57.58 million, a PE ratio of -15.76 and a beta of 1.16. OneMedNet Corporation has a 1-year low of $0.31 and a 1-year high of $4.22. </p><p>OneMedNet (NASDAQ:ONMD - Get Free Report) last issued its quarterly earnings data on Monday, March 30th. The company reported ($0.07) earnings per share (EPS) for the quarter. The firm had revenue of $0.89 million during the quarter. </p><h2>Analyst Upgrades and Downgrades</h2><p>Separately, Weiss Ratings  reaffirmed a &#34;sell (d-)&#34; rating on shares of OneMedNet in a report on Friday, January 9th. One research analyst  has rated the stock with a Sell rating,  According to MarketBeat, OneMedNet presently has an average rating of &#34;Sell&#34;.</p><p><b>Read Our Latest Research Report on OneMedNet</b></p><h2>Institutional Trading of OneMedNet</h2><p>Several hedge funds and other institutional investors have recently bought and sold shares of ONMD. Ashton Thomas Private Wealth LLC bought a new stake in  OneMedNet in the 3rd quarter valued at about $25,000.  HRT Financial LP bought a new position in shares of  OneMedNet during the fourth quarter worth approximately $32,000.  State Street Corp raised its position in shares of  OneMedNet by 41.5% in the fourth quarter. State Street Corp now owns 116,700 shares of the company's stock valued at $128,000 after buying an additional 34,200 shares in the last quarter.  Virtu Financial LLC acquired a new stake in shares of  OneMedNet in the fourth quarter valued at approximately $48,000.  Finally, Exencial Wealth Advisors LLC boosted its stake in shares of  OneMedNet by 1.3% in the fourth quarter. Exencial Wealth Advisors LLC now owns 3,644,861 shares of the company's stock valued at $4,009,000 after buying an additional 45,401 shares during the period. Institutional investors and hedge funds own  0.95% of the company's stock. </p><h2>OneMedNet Company Profile</h2> (Get Free Report)<p>OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota. </p><h2>Featured Articles</h2><ul><li>Five stocks we like better than OneMedNet</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9T05NRA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9T05NRA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in OneMedNet Right Now?</h2><p>Before you consider OneMedNet, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and OneMedNet wasn't on the list.</p><p>While OneMedNet currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

ONMD

ONMDW

<p>OneMedNet Corporation (NASDAQ:ONMD) Director Thomas Kosasa purchased 595,238 shares at $0.84 each, totaling $499,999.92, on February 6th. This acquisition increased his holdings to 16,380,429 shares, valued at approximately $13.76 million. The stock rose 24.1% to $1.10 during trading. Despite this, Weiss Ratings maintains a "sell (d-)" rating on the stock, which has a market cap of $57.58 million and a PE ratio of -15.76. Institutional investors own 0.95% of the company, which specializes in clinical imaging solutions.</p>

Market Beat

OneMedNet

ONEMEDNET CORP C/WTS 07/11/2028 (TO PUR COM)

Palantir Tech

State Street

Virtu Finc

State Street® US Equity Premium Inc ETF

Insider Buying: OneMedNet (NASDAQ:ONMD) Director Acquires 595,238 Shares of Stock